Abstract
Using cyclodextrin helps make different dosage forms more soluble. The oligosaccharide class known as cyclodextrins (CDs) is made up of glucose units bound together in a ring. CDs have the promising ability to assemble into complexes with drug molecules and improve their physicochemical properties without the need for molecular modifications. Generally, drug-CD complexes have a stoichiometry of 1:1. However, natural CDs have a tendency to self-assemble and form aggregates in aqueous media, which can reduce the solubility of the CDs by aggregating. One can increase their complexation capacity and solubility through derivative formation, but the final outcome depends on the kind and extent of substitution. Drug penetration through biological membranes can be improved by the formation of water-soluble drug-CD complexes. Solubility is the property of a solid dissolving into a liquid phase to form a homogenous system. Solubility is a crucial component in obtaining the right drug concentration in the systemic circulation for the optimal pharmacological response. Orally administered poorly soluble drugs often require high dosages to reach therapeutic plasma concentrations. Their low solubility in water is one of the primary problems with creating new chemical entities through formulation. The BCS classification system places these medications in class II, which is characterized by high permeability and poor solubility. To greatly improve these medications, it is possible to make them more bioavailable and soluble.
Publisher
Innovare Academic Sciences Pvt Ltd
Reference32 articles.
1. Ain S, Kumar B, Pathak K. Cyclodextrins: versatile carrier in drug formulations and delivery systems. Int J Pharm Chem Biol Sci. 2015 Jul 1;5(3):583-98.
2. Saokham P, Muankaew C, Jansook P, Loftsson T. Solubility of cyclodextrins and drug/cyclodextrin complexes. Molecules. 2018 May 11;23(5):1161. doi: 10.3390/molecules23051161, PMID 29751694.
3. Shimpi S, Chauhan B, Shimpi P. Cyclodextrins: application in different routes of drug administration. Acta Pharm. 2005 Jun 1;55(2):139-56. PMID 16179128.
4. Del Valle EMM. Cyclodextrins and their uses: a review. Process Biochem. 2004 May 31;39(9):1033-46. doi: 10.1016/S0032-9592(03)00258-9.
5. Muankaew C, Loftsson T. Cyclodextrin‐based formulations: a non‐invasive platform for targeted drug delivery. Basic Clin Pharmacol Toxicol. 2018 Jan;122(1):46-55. doi: 10.1111/bcpt.12917, PMID 29024354.